Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature

Effects of Vascular-Endothelial Protein Tyrosine Phosphatase Inhibition on Breast Cancer Vasculature and Metastatic Progression

(2013) Shom Goel et al.   JNCI-Journal of the National Cancer Institute

Long-term Outcomes in Patients with Retinal Vein Occlusion Treated with Ranibizumab

(2013) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Skeletal Muscle–Specific Genetic Determinants Contribute to the Differential Strain-Dependent Effects of Hindlimb Ischemia in Mice

(2012) Joseph M. McClung et al.   AMERICAN JOURNAL OF PATHOLOGY

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Ranibizumab for Diabetic Macular Edema

(2012) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo

(2011) Andre Broermann et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The 1-year Results of CLEAR-IT 2, a Phase 2 Study of Vascular Endothelial Growth Factor Trap-Eye Dosed As-needed After 12-week Fixed Dosing

(2011) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Vascular cell-adhesion molecule-1 plays a central role in the proangiogenic effects of oxidative stress

(2011) A. Dong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Digoxin inhibits retinal ischemia-induced HIF-1α expression and ocular neovascularization

(2010) Tsunehiko Yoshida et al.   FASEB JOURNAL

Agents that bind annexin A2 suppress ocular neovascularization

(2010) Raquel Lima e Silva et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion

(2010) Peter A. Campochiaro et al.   OPHTHALMOLOGY

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Ranibizumab for Macular Edema following Central Retinal Vein Occlusion

(2010) David M. Brown et al.   OPHTHALMOLOGY

Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells

(2009) Orisha K. Yacyshyn et al.   ANGIOGENESIS

VE-PTP controls blood vessel development by balancing Tie-2 activity

(2009) Mark Winderlich et al.   JOURNAL OF CELL BIOLOGY

Angiopoietin 2 Is a Partial Agonist/Antagonist of Tie2 Signaling in the Endothelium

(2009) H. T. Yuan et al.   MOLECULAR AND CELLULAR BIOLOGY

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

(2009) Hellmut G. Augustin et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor

(2009) Katsuaki Miki et al.   OPHTHALMOLOGY

Structurally Distinct Phosphatases CD45 and CD148 Both Regulate B Cell and Macrophage Immunoreceptor Signaling

(2008) Jing W. Zhu et al.   IMMUNITY

VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF

(2008) Astrid F. Nottebaum et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Implication of VEGF as a Critical Stimulator

(2008) Peter A Campochiaro et al.   MOLECULAR THERAPY